Dr. Nizar N. Zein is the Chairman of Global Patient Services for the Cleveland Clinic and will present at the Bupa Global Providers Summit, part of the World Medical Tourism & Global Healthcare Congress in Orlando from September 27 – 30.
Dr. Zein is the Chief of Hepatology and the inaugural endowed holder of the Mikati Foundation Chair in Liver Diseases.He is the recipient of several awards including the American Liver Foundation Scholar Award, the Cleveland Clinic Innovator Award, the Distinguished Faculty Award for Research Mentorship, recognition for academic excellence by the Syrian American Medical Society and honors for his leadership and community service by the Ana G. Mendez University of Puerto Rico as the recipient of Presidential Medal in 2011. He was elected to the Board of Governors of the Cleveland Clinic in 2015.
In his role as a researcher, Dr. Zein focuses on improving disease and treatment outcomes for patients with Hepatitis C before and after liver transplant. He is the author of over 200 publications has served as the principal investigator of several large clinical trials. He has also served as the Editor of “The Year in Gastroenterology and Hepatology” associate editor of the American Journal of Gastroenterology, Special Section Editor of “Liver Transplantation” and an editorial board member of Hepatology and Gastroenterology & Hepatology.
Dr. Zein is involved in the education of fellows and residents at the Cleveland Clinic and has been recognized by the Cleveland Clinic Lerner College of Medicine as Teacher of the Year.
The Bupa Global Provider Summit allows participants to discuss the different drivers, including clinical quality, that have increased the competitiveness and differentiation in the provision of international healthcare services. The summit will present experiences from medical providers from around the world which have been successful in attracting international customers along the years. Additionally, the event will facilitate the discussion of the role that the different stakeholders (hospitals, doctors, accreditation bodies, international insurers) have played and should play in improving the quality of private healthcare services internationally.